Public batch ID: BPC157-B002 Current batch Batch B002 Janoshik Analytical batch-specific analytical report Proves identity Proves purity Checks amount Sterility not tested unless listed Prior batches Batch B001 March 2026 - Janoshik verified Research & library Research review Scientific background, literature, and compound context COA library Browse current and supporting batch documentation Scope limit: COAs document analytical testing for research materials
Baxter, M
We will administer fluids to women in their 1st and 2nd trimester, with a note from their health care provider and approval from our medical director
Interactions with other medications have not been systematically characterized potential interactions with CNS depressants (alcohol, sedatives, anxiolytics), opioids, or other psychoactive substances should be considered, though documented problematic interactions are not prominent in available literature
ClinicalTrials.gov - Search for ongoing and completed clinical trials involving neuropeptides, Cerebrolysin, and novel brain-targeting peptide therapies
